OTCMKTS:MEOBF

Mesoblast Short Interest Ratio and Short Volume

$1.40
0.00 (0.00 %)
(As of 07/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.40
$1.40
50-Day Range
$1.26
$1.74
52-Week Range
$1.26
$9.99
Volume80,000 shs
Average Volume57,204 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Mesoblast (OTCMKTS:MEOBF) Short Interest Data

Current Short Volume6,220,900 shares
Previous Short Volume6,220,900 shares
Change Vs. Previous MonthNo Change
Dollar Volume Sold Short$9.46 million
Short Interest Ratio / Days to Cover723.4
Last Record DateJune, 30 2021
Today's Trading Volume80,000 shares
Average Trading Volume57,204 shares
Today's Volume Vs. Average39.85%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Mesoblast ?

Sign up to receive the latest short interest report for Mesoblast and its competitors with MarketBeat's FREE newsletter.

Mesoblast (OTCMKTS:MEOBF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20216,220,900 shares $9.46 million No ChangeN/A723.4 $1.52
6/15/20216,220,900 shares $10.14 million -0.6%N/A100.7 $1.63
5/28/20216,259,100 shares $9.14 million +0.6%N/A680.3 $1.46
5/14/20216,221,300 shares $8.34 million -4.0%N/A63.4 $1.34
4/30/20216,479,700 shares $10.70 million 0.0%N/A64797 $1.65
4/15/20216,480,900 shares $11.15 million +0.9%N/A641.7 $1.72
3/31/20216,425,600 shares $11.11 million +0.6%N/A170.9 $1.73
3/15/20216,385,000 shares $11.24 million -10.8%N/A107 $1.76
2/26/20217,160,500 shares $13.96 million -14.6%N/A3580.3 $1.95
2/12/20218,385,100 shares $16.60 million -24.5%N/A1582.1 $1.98
1/29/202111,105,000 shares $19.77 million +7.3%N/A437.2 $1.78
1/15/202115,693,300 shares $31.07 million +0.1%N/A10462.2 $1.98
12/31/202010,553,300 shares $18.26 million -32.8%N/A210.6 $1.73
12/15/202015,693,300 shares $54.14 million +0.1%N/A10462.2 $3.45
11/30/202015,671,500 shares $45.60 million -3.3%N/A712.3 $2.91
11/15/202016,200,800 shares $36.61 million -3.0%N/A623.1 $2.26
10/30/202016,708,500 shares $35.92 million +2.3%N/A269.5 $2.15
10/15/202016,329,800 shares $38.54 million -6.0%N/A1158.1 $2.36
9/30/202017,366,200 shares $66.17 million -0.4%N/A460.6 $3.81
9/15/202017,432,500 shares $56.66 million -7.1%N/A19369.4 $3.25
8/31/202018,764,100 shares $75.06 million +11.3%N/A1008.8 $4.00
8/14/202016,865,400 shares $59.03 million +5.1%N/A5270.4 $3.50
7/31/202016,048,900 shares $43.33 million +6.4%N/A22927 $2.70
7/15/202015,087,200 shares $30.93 million +7.9%N/A150872 $2.05
6/30/202013,983,800 shares $28.67 million +1.3%N/A8225.8 $2.05

Mesoblast (OTCMKTS:MEOBF) Short Interest FAQ

speech bubbles
speech bubbles











What is Mesoblast's current short interest?

Short interest is the volume of Mesoblast shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 6,220,900 shares of MEOBF short. Learn More on Mesoblast's current short interest.

What is a good short interest ratio for Mesoblast?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Mesoblast currently has a short interest ratio of 723.0. Learn More on a good short interest ratio for Mesoblast

How does Mesoblast's short interest compare to its competitors?

0.00% of Mesoblast's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Mesoblast: Algernon Pharmaceuticals Inc. (0.00%), Almirall, S.A. (0.00%), AXIM Biotechnologies, Inc. (0.00%), BerGenBio ASA (0.00%), Cannabics Pharmaceuticals Inc. (0.00%), Cassiopea S.p.A. (0.00%), Cerebain Biotech Corp. (0.00%), Claritas Pharmaceuticals, Inc. (0.00%), Clinuvel Pharmaceuticals Limited (0.00%), and Creative Medical Technology Holdings, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Square, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks.

What does it mean to sell short Mesoblast stock?

Short selling MEOBF is an investing strategy that aims to generate trading profit from Mesoblast as its price is falling. To short Mesoblast stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Mesoblast will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mesoblast?

A short squeeze for Mesoblast occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEOBF, which in turn drives the price of the stock up even further.

How often is Mesoblast's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEOBF, twice per month. The most recent reporting period available is June, 30 2021.



This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.